Bogle Investment Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bogle Investment Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-17,974	Closed	-$2.55M	–	193
2020 Q3	$2.55M	Sell	17,974 -5,206	-22%	-$868K	0.75%	69
2020 Q2	$4.57M	Sell	23,180 -24,991	-52%	-$5.18M	0.76%	31
2020 Q1	$9.44M	Buy	48,171 +8,667	+22%	+$1.86M	0.99%	44
2019 Q4	$8.17M	Buy	39,504 +25,848	+189%	+$4.78M	0.76%	51
2019 Q3	$2.08M	Buy	+13,656	New	+$2.24M	0.18%	128
2017 Q2	–	Sell	-4,281	Closed	-$368K	–	328
2017 Q1	$368K	Buy	+4,281	New	+$308K	0.03%	274
2015 Q4	–	Sell	-25,192	Closed	-$1.02M	–	402
2015 Q3	$1.02M	Buy	+25,192	New	+$1.45M	0.07%	263

Other funds holding LKFT

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bogle Investment Management's LKFT Position: Q4 2020 in Review

Bogle Investment Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2020, closing a stake of 17,974 shares — an estimated $2.55M sold.

Bogle Investment Management first reported a position in LKFT in Q3 2015 and held it in 7 quarters. The position peaked at $9.44M in Q1 2020. 116 funds tracked by Wall St. Rank hold LKFT as of Q4 2020.

Bogle Investment Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2020 after selling out during the quarter.
Bogle Investment Management sold 17,974 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2020, an estimated $2.55M.
Bogle Investment Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2015 and held it in 7 quarters.
Bogle Investment Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $9.44M in Q1 2020.
116 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2020.

Based on Bogle Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.